Provider Resources WA

01/08/22 Health Advisory: CDC updated Antiviral Guidance; Booster Eligibility Expanded

tongue depressors and cotton swabs on physician's desk

COVID-19 Updates for Providers Requested actions Updated Antiviral Guidance Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit 01/08/22 Health Advisory: CDC updated Antiviral Guidance; Booster Eligibility Expanded

11/08/21 Health Advisory: COVID-19 Monoclonal Antibody and Testing Updates

Overhead image of four providers in a huddle

Requested Actions Be aware, Washington State is currently experiencing a shortage of anti-SARS-CoV-2 monoclonal antibodies (MAbs). Adhere to National Institutes of Health (NIH) guidelines on the use and prioritization of MAbs. Do not administer or prescribe Ivermectin for prevention or treatment of COVID-19. CDC issued a health alert about the rapid increase in Ivermectin prescriptions and reports 11/08/21 Health Advisory: COVID-19 Monoclonal Antibody and Testing Updates

11/08/21 Health Advisory: COVID-19 Vaccine 3rd and Booster Doses

syringe in a vial

Requested Actions  Be aware of the confusion between the terminology and guidance for 3rd dose versus booster doses. 3rd dose: vaccine doses available now for people who are considered moderately or severely immunocompromised On August 12, the  Food and Drug Administration (FDA) amended its emergency use authorizations (EUAs) for Pfizer and Moderna COVID-19 vaccines to allow an additional (third) dose 11/08/21 Health Advisory: COVID-19 Vaccine 3rd and Booster Doses

11/08/21 Health Advisory: COVID-19 Vaccine For Ages 5-11

Children's hands with paint

Requested actions Be aware, on Nov. 2, Centers for Disease Control and Prevention (CDC) recommended the Pfizer-BioNTech vaccine for children 5–11 years old under the Food and Drug Administration’s (FDA’s) emergency use authorization (EUA). Be aware, the U.S. is experiencing a shortage of BinaxNOW COVID-19 rapid antigen tests. Background COVID-19 vaccine for children 5–11 years 11/08/21 Health Advisory: COVID-19 Vaccine For Ages 5-11

Hepatitis A Fact Sheet

Gloved hand squeeze bicep while giving a shot.

Overview Transmission: Fecal-oral. Incubation Period: Average 28-30 days (range 15-50 days). Symptoms: Anorexia, vomiting, abdominal pain, fatigue, followed by jaundice. Severity of illness increases with age. Infectious Period: 14 days prior to onset of jaundice to seven days after onset of jaundice. Infants can excrete virus in the stool for longer periods of time. Epidemiology: Hepatitis A Fact Sheet

Hand Hygiene In Healthcare Settings

Handwashing over stainless steel sink.

What is hand hygiene? Hand hygiene refers to the use of hand washing with soap and water or alcohol hand sanitizer (60% alcohol or greater) in order to reduce infection rates, reduce transmission of antimicrobial resistant organisms and stop outbreaks of communicable disease. Why is hand hygiene important? When should I use hand hygiene? How Hand Hygiene In Healthcare Settings